Daxor Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
-
-
2,455.60
2,183.90
1,089.20
390.70
Total Assets
47,394.20
46,046.20
20,893.30
20,624.40
19,311.20
17,626.50
Deferred Taxes
17.20
1,219.60
-
-
-
Other Liabilities
778.30
109.20
2,620.70
2,478.40
1,219.00
Total Liabilities
21,023.40
21,465.50
6,465.80
5,280.10
5,553.60
Common Equity (Total)
26,370.80
24,580.70
14,427.50
15,344.30
13,757.60
Total Shareholders' Equity
26,370.80
24,580.70
14,427.50
15,344.30
13,757.60
Total Equity
26,370.80
24,580.70
14,427.50
15,344.30
13,757.60
Liabilities & Shareholders' Equity
47,394.20
46,046.20
20,893.30
20,624.40
19,311.20
Short-Term Receivables
1,389.30
324.80
33.40
435.10
45.30
390.70
Investments - Total
45,987.70
44,477.40
18,376.20
17,972.20
18,138.90
17,235.80
Other Assets (Including Intangibles)
-
24.50
28.20
33.20
37.80
-
Total Debt
20,245.10
21,356.30
3,845.10
2,801.70
4,334.60

About Daxor

View Profile
Address
Empire State Building
New York New York 10118
United States
Employees -
Website http://www.daxor.com
Updated 07/08/2019
Daxor Corp. is a biotechnology company which develops and manufactures BVA-100 blood volume analyzer, an instrument that measures human blood volume. Its IDANT division provides autologous blood storage; and andrology services, such as semen analysis, sperm washing and general lab testing. The company was founded by Joseph Feldschuh in 1970 and is headquartered in New York, NY.